医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Inclusion of Pediatric Vaccines in National Immunization Programs Will Boost the Global Preventable Vaccines Market by 2019: TechNavio

2015年02月18日 AM12:35
このエントリーをはてなブックマークに追加


 

LONDON

TechNavio has announced the publication of a new market research report on the Global Preventable Vaccines Market, which is expected to grow at a CAGR of 10.16 percent from 2014-2019.

About the Report

According to the latest report by TechNavio, the inclusion of vaccinations in the national immunization programs of many countries will increase the accessibility of vaccines to low-income families. Various governments are conducting routine immunization schedules to ensure that vaccines are available to both adults and children.

“The Government of Australia has incorporated pediatric and adult vaccinations in their programs, and the UK government has started a childhood immunization schedule with quick guidelines for parents,” says Faisal Ghaus, Vice President of TechNavio.

The latest report by TechNavio draws attention towards increasing strategic alliances that are aimed at enhancing the product portfolio of parent companies. Large pharmaceutical companies are focused on consolidating their position in the market and increasing their respective market shares.

Additionally, vaccine manufacturers are shifting their bases to developing countries in order to capitalize on the favorable business conditions in these countries.

“Global players are targeting countries like India and China as vaccine development hubs because of the availability of skilled manpower, excellent manufacturing capabilities and low-manufacturing costs,” says Ghaus.

Key Information Covered in the Report:

  • Market segmentation, size and forecast through 2019
  • Market Growth Drivers:
  • Market Challenges:
  • Market Trends:
  • Key Vendors:
    • GlaxoSmithKline plc
    • Merck and Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
  • Other Prominent Vendors:
    • Abbott
    • Bavarian Nordic
    • Baxter
    • bioCSL

TechNavio currently has more than 3000 market research reports on a huge range of topics, including 300+ reports on the vaccines market:

If you are interested in more information, please contact our media team at media@technavio.com.

CONTACT

TechNavio Research
Jes Ellacott
US: +1-630-333-9501
UK:
+44 208 123 1770
Media & Marketing Executive
www.technavio.com
media@technavio.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Philip Morris International Launches Next Generation of IQOS, the World’s Leading Heated Tobacco Product
  • PotNetwork Holdings, Inc.第三季度业绩创纪录,营收超过610万美元
  • ポットネットワーク・ホールディングスが610万ドルを超える収益で過去最高の第3四半期を終える
  • ポットネットワーク・ホールディングスがSEC報告会社となるためにフォーム10を提出
  • Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing a Falsified Company Seal and Forged Board Member Signatures